fiercebiotechAugust 08, 2017
Tag: R&D fix , LEO Pharma , Stanford University
> GlaxoSmithKline CEO Emma Walmsley outlined her fix for the company's long-standing pipeline woes. The plan is to give the commercial team a bigger say in pipeline decisions. Article
> Leo Pharma formed a research collaboration with HitGen. The agreement will see HitGen turn its technology on targets of interest to Leo. Statement
> Alligator Bioscience expanded its immuno-oncology collaboration with Stanford University. Release
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: